{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:41:35Z","timestamp":1792813295903,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41401-025-01701-9","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:05:32Z","timestamp":1769511932000},"page":"1361-1373","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["AI and experimental convergence: a synergistic pathway to JAK2 inhibitor discovery"],"prefix":"10.1038","volume":"47","author":[{"family":"Maryam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwangeui","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Pokhrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sourav","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Jung","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kil To","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilal","family":"Tayara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"key":"1701_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2004-5-12-253","volume":"5","author":"K Yamaoka","year":"2004","unstructured":"Yamaoka K, Saharinen P, Pesu M, Holt VET, Silvennoinen O, O\u2019Shea JJ. The janus kinases (jaks). Genome Biol. 2004;5:1\u20136.","journal-title":"Genome Biol"},{"key":"1701_CR2","first-page":"1347","volume":"7","author":"AG Harpur","year":"1992","unstructured":"Harpur AG, Andres AC, Ziemiecki A, Aston RR, Wilks AF. JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene. 1992;7:1347\u201353.","journal-title":"Oncogene"},{"key":"1701_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1600-065X.2008.00754.x","volume":"228","author":"K Ghoreschi","year":"2009","unstructured":"Ghoreschi K, Laurence A, O\u2019Shea JJ. Janus kinases in immune cell signaling. Immunol Rev. 2009;228:273\u201387.","journal-title":"Immunol Rev"},{"key":"1701_CR4","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jaci.2020.10.022","volume":"147","author":"W Damsky","year":"2021","unstructured":"Damsky W, Peterson D, Ramseier J, Al-Bawardy B, Chun H, Proctor D, et al. The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases. J Allergy Clin Immunol. 2021;147:814\u201326.","journal-title":"J Allergy Clin Immunol"},{"key":"1701_CR5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/cancers13040800","volume":"13","author":"J Raivola","year":"2021","unstructured":"Raivola J, Haikarainen T, Abraham BG, Silvennoinen O. Janus kinases in leukemia. Cancers. 2021;13:800.","journal-title":"Cancers"},{"key":"1701_CR6","doi-asserted-by":"crossref","unstructured":"Kumar N, Kuang L, Villa R, Kumar P, Mishra J. Mucosal epithelial Jak kinases in health and diseases. Mediators Inflamm. 2021;2021:6618924.","DOI":"10.1155\/2021\/6618924"},{"key":"1701_CR7","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.bcp.2011.12.024","volume":"83","author":"MM Seavey","year":"2012","unstructured":"Seavey MM, Dobrzanski P. The many faces of Janus kinase. Biochem Pharmacol. 2012;83:1136\u201345.","journal-title":"Biochem Pharmacol"},{"key":"1701_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41584-021-00726-8","volume":"18","author":"Y Tanaka","year":"2022","unstructured":"Tanaka Y, Luo Y, O\u2019Shea JJ, Nakayamada S. Janus kinase-targeting therapies in rheumatology: a mechanisms-based approach. Nat Rev Rheumatol. 2022;18:133\u201345.","journal-title":"Nat Rev Rheumatol"},{"key":"1701_CR9","doi-asserted-by":"publisher","first-page":"417","DOI":"10.2174\/1566524020666201015144702","volume":"21","author":"M Sopjani","year":"2021","unstructured":"Sopjani M, Morina R, Uka V, Xuan NT, D\u00ebrmaku-Sopjani M. JAK2-mediated intracellular signaling. Curr Mol Med. 2021;21:417\u201325.","journal-title":"Curr Mol Med"},{"key":"1701_CR10","doi-asserted-by":"publisher","first-page":"300","DOI":"10.7326\/0003-4819-152-5-201003020-00008","volume":"152","author":"JL Spivak","year":"2010","unstructured":"Spivak JL. Narrative review: thrombocytosis, polycythemia vera, and JAK2 mutations: the phenotypic mimicry of chronic myeloproliferation. Ann Intern Med. 2010;152:300\u20136.","journal-title":"Ann Intern Med"},{"key":"1701_CR11","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/ajh.22063","volume":"86","author":"LM Scott","year":"2011","unstructured":"Scott LM. The JAK2 exon 12 mutations: a comprehensive review. Am J Hematol. 2011;86:668\u201376.","journal-title":"Am J Hematol"},{"key":"1701_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.blre.2010.10.004","volume":"25","author":"FPS Santos","year":"2011","unstructured":"Santos FPS, Verstovsek S. JAK2 inhibitors: what\u2019s the true therapeutic potential?. Blood Rev. 2011;25:53\u201363.","journal-title":"Blood Rev"},{"key":"1701_CR13","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(05)71142-9","volume":"365","author":"EJ Baxter","year":"2005","unstructured":"Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054\u201361.","journal-title":"Lancet"},{"key":"1701_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.leukres.2014.11.018","volume":"39","author":"S Verstovsek","year":"2015","unstructured":"Verstovsek S, Hoffman R, Mascarenhas J, Soria JC, Bahleda R, McCoon P, et al. A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis. Leuk Res. 2015;39:157\u201363.","journal-title":"Leuk Res"},{"key":"1701_CR15","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamaoncol.2015.1590","volume":"1","author":"A Pardanani","year":"2015","unstructured":"Pardanani A, Harrison C, Cortes JE, Cervantes F, Mesa RA, Milligan D, et al. Safety and efficacy of fedratinib in patients with primary or secondary myelofibrosis: a randomized clinical trial. JAMA Oncol. 2015;1:643\u201351.","journal-title":"JAMA Oncol"},{"key":"1701_CR16","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1002\/jcc.27103","volume":"44","author":"S Belenahalli Shekarappa","year":"2023","unstructured":"Belenahalli Shekarappa S, Kandagalla S, Lee J. Development of machine learning models based on molecular fingerprints for selection of small molecule inhibitors against JAK2 protein. J Comput Chem. 2023;44:1493\u2013504.","journal-title":"J Comput Chem"},{"key":"1701_CR17","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","volume":"25","author":"R Gupta","year":"2021","unstructured":"Gupta R, Srivastava D, Sahu M, Tiwari S, Ambasta RK, Kumar P. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers. 2021;25:1315\u201360.","journal-title":"Mol Divers"},{"key":"1701_CR18","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1016\/j.drudis.2017.08.010","volume":"22","author":"L Zhang","year":"2017","unstructured":"Zhang L, Tan J, Han D, Zhu H. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Drug Discov Today. 2017;22:1680\u20135.","journal-title":"Drug Discov Today"},{"key":"1701_CR19","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1021\/acsmedchemlett.8b00500","volume":"9","author":"AM Jordan","year":"2018","unstructured":"Jordan AM. Artificial intelligence in drug design\u2014the storm before the calm?. ACS Med Chem Lett. 2018;9:1150\u20132.","journal-title":"ACS Med Chem Lett"},{"key":"1701_CR20","doi-asserted-by":"publisher","DOI":"10.1017\/S0269888919000225","volume":"34","author":"R Beal","year":"2019","unstructured":"Beal R, Norman TJ, Ramchurn SD. Artificial intelligence for team sports: a survey. Knowl Eng Rev. 2019;34:e28.","journal-title":"Knowl Eng Rev"},{"key":"1701_CR21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.tips.2019.05.005","volume":"40","author":"S Harrer","year":"2019","unstructured":"Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends Pharmacol Sci. 2019;40:577\u201391.","journal-title":"Trends Pharmacol Sci"},{"key":"1701_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2023.168314","volume":"435","author":"BA Mir","year":"2023","unstructured":"Mir BA, Rehman MU, Tayara H, Chong KT. Improving enhancer identification with a multi-classifier stacked ensemble model. J Mol Biol. 2023;435:168314.","journal-title":"J Mol Biol"},{"key":"1701_CR23","doi-asserted-by":"crossref","unstructured":"Mir BA, Tayara H, Chong KT. SB-Net: synergizing CNN and LSTM networks for uncovering retrosynthetic pathways in organic synthesis. Comput Biol Chem. 2024;112:108130.","DOI":"10.1016\/j.compbiolchem.2024.108130"},{"key":"1701_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.107724","volume":"168","author":"S Gaffar","year":"2024","unstructured":"Gaffar S, Hassan MT, Tayara H, Chong KT. IF-AIP: a machine learning method for the identification of anti-inflammatory peptides using multi-feature fusion strategy. Comput Biol Med. 2024;168:107724.","journal-title":"Comput Biol Med"},{"key":"1701_CR25","doi-asserted-by":"crossref","unstructured":"Hassan MT, Tayara H, Chong KT. Possum: identification and interpretation of potassium ion inhibitors using probabilistic feature vectors. Arch Toxicol. 2025;99:225\u2013235.","DOI":"10.1007\/s00204-024-03888-y"},{"key":"1701_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.109087","volume":"182","author":"Z Abbas","year":"2024","unstructured":"Abbas Z, Rehman MU, Tayara H, Lee SW, Chong KT. m5C-Seq: machine learning-enhanced profiling of RNA 5-methylcytosine modifications. Comput Biol Med. 2024;182:109087.","journal-title":"Comput Biol Med"},{"key":"1701_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108729","volume":"179","author":"MU Rehman","year":"2024","unstructured":"Rehman MU, Hussain I, Tayara H, Chong KT. others. A graph neural network approach for predicting drug susceptibility in the human microbiome. Comput Biol Med. 2024;179:108729.","journal-title":"Comput Biol Med"},{"key":"1701_CR28","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s11427-018-9342-2","volume":"61","author":"F Zhong","year":"2018","unstructured":"Zhong F, Xing J, Li X, Liu X, Fu Z, Xiong Z, et al. Artificial intelligence in drug design. Sci China Life Sci. 2018;61:1191\u2013204.","journal-title":"Sci China Life Sci"},{"key":"1701_CR29","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10822-020-00317-x","volume":"34","author":"N Brown","year":"2020","unstructured":"Brown N, Ertl P, Lewis R, Luksch T, Reker D, Schneider N. Artificial intelligence in chemistry and drug design. J Comput Aided Mol Des. 2020;34:709\u201315.","journal-title":"J Comput Aided Mol Des"},{"key":"1701_CR30","doi-asserted-by":"publisher","first-page":"5002","DOI":"10.1021\/acs.jcim.9b00798","volume":"59","author":"M Yang","year":"2019","unstructured":"Yang M, Tao B, Chen C, Jia W, Sun S, Zhang T, et al. Machine learning models based on molecular fingerprints and an extreme gradient boosting method lead to the discovery of JAK2 inhibitors. J Chem Inf Model. 2019;59:5002\u201312.","journal-title":"J Chem Inf Model"},{"key":"1701_CR31","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1021\/jm101157q","volume":"54","author":"G Thoma","year":"2011","unstructured":"Thoma G, Nuninger F, Falchetto R, Hermes E, Tavares GA, Vangrevelinghe E, et al. Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family. J Med Chem. 2011;54:284\u20138.","journal-title":"J Med Chem"},{"key":"1701_CR32","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/ci9803381","volume":"39","author":"D Butina","year":"1999","unstructured":"Butina D. Unsupervised data base clustering based on daylight\u2019s fingerprint and Tanimoto similarity: a fast and automated way to cluster small and large data sets. J Chem Inf Comput Sci. 1999;39:747\u201350.","journal-title":"J Chem Inf Comput Sci"},{"key":"1701_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers D, Hahn M. Extended-connectivity fingerprints. J Chem Inf Model. 2010;50:742\u201354.","journal-title":"J Chem Inf Model"},{"key":"1701_CR34","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD \u201916). Association for Computing Machinery, New York, NY, USA; 2016. p. 785\u201394.","DOI":"10.1145\/2939672.2939785"},{"key":"1701_CR35","doi-asserted-by":"crossref","unstructured":"Wu J, Kong L, Yi M, Chen Q, Cheng Z, Zuo H, et al. Prediction and screening model for products based on fusion regression and xgboost classification. Comput Intell Neurosci. 2022;2022:4987639.","DOI":"10.1155\/2022\/4987639"},{"key":"1701_CR36","doi-asserted-by":"crossref","unstructured":"Schapire RE. Explaining adaboost. Empirical inference: festschrift in honor of vladimir N Vapnik. Springer; 2013. p37\u201352.","DOI":"10.1007\/978-3-642-41136-6_5"},{"key":"1701_CR37","doi-asserted-by":"publisher","first-page":"107912","DOI":"10.1016\/j.cie.2021.107912","volume":"165","author":"E Sevin\u00e7","year":"2022","unstructured":"Sevin\u00e7 E. An empowered AdaBoost algorithm implementation: a COVID-19 dataset study. Comput Ind Eng. 2022;165:107912.","journal-title":"Comput Ind Eng"},{"key":"1701_CR38","doi-asserted-by":"crossref","unstructured":"Friedman JH. Greedy function approximation: A gradient boosting machine. Ann Statis. 2001;29:1189\u2013232.","DOI":"10.1214\/aos\/1013203451"},{"key":"1701_CR39","unstructured":"Prokhorenkova L, Gusev G, Vorobev A, Dorogush AV, Gulin A. CatBoost: unbiased boosting with categorical features. In: Advances in Neural Information Processing Systems 31 (NeurIPS 2018). p. 6638\u201348."},{"key":"1701_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40537-020-00369-8","volume":"7","author":"JT Hancock","year":"2020","unstructured":"Hancock JT, Khoshgoftaar TM. CatBoost for big data: an interdisciplinary review. J Big Data. 2020;7:1\u201345.","journal-title":"J Big Data"},{"key":"1701_CR41","doi-asserted-by":"crossref","unstructured":"Akiba T, Sano S, Yanase T, Ohta T, Koyama M. Optuna: a next-generation hyperparameter optimization framework. In: Proceedings of the 25th ACM SIGKDD international conference on knowledge discovery & data mining. 2019. p2623\u201331.","DOI":"10.1145\/3292500.3330701"},{"key":"1701_CR42","doi-asserted-by":"crossref","unstructured":"Kramer O. Scikit-learn. In: Machine learning for evolution strategies. Cham: Springer International Publishing; 2016. p45\u201353.","DOI":"10.1007\/978-3-319-33383-0_5"},{"key":"1701_CR43","doi-asserted-by":"crossref","unstructured":"Cook J, Ramadas V. When to consult precision-recall curves. Stata J. 2020;20:131\u201348.","DOI":"10.1177\/1536867X20909693"},{"key":"1701_CR44","unstructured":"Wu S, Flach P. A scored AUC metric for classifier evaluation and selection. In: Second workshop on ROC analysis in machine learning. Bonn, Germany. 2005."},{"key":"1701_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-023-00322-4","volume":"16","author":"D Chicco","year":"2023","unstructured":"Chicco D, Jurman G. The Matthews correlation coefficient (MCC) should replace the ROC AUC as the standard metric for assessing binary classification. BioData Min. 2023;16:4.","journal-title":"BioData Min"},{"key":"1701_CR46","first-page":"220","volume":"26","author":"S Narkhede","year":"2018","unstructured":"Narkhede S. Understanding auc-roc curve. Towar Data Sci. 2018;26:220\u20137.","journal-title":"Towar Data Sci"},{"key":"1701_CR47","doi-asserted-by":"publisher","first-page":"128067","DOI":"10.1016\/j.bmcl.2021.128067","volume":"42","author":"JY Lee","year":"2021","unstructured":"Lee JY, Kuo CJ, Shin JS, Jung E, Liang PH, Jung YS. Identification of non-covalent 3C-like protease inhibitors against severe acute respiratory syndrome coronavirus-2 via virtual screening of a Korean compound library. Bioorg Med Chem Lett. 2021;42:128067.","journal-title":"Bioorg Med Chem Lett"},{"key":"1701_CR48","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.3390\/molecules25204723","volume":"25","author":"J V\u00e1zquez","year":"2020","unstructured":"V\u00e1zquez J, L\u00f3pez M, Gibert E, Herrero E, Luque FJ. Merging ligand-based and structure-based methods in drug discovery: an overview of combined virtual screening approaches. Molecules. 2020;25:4723.","journal-title":"Molecules"},{"key":"1701_CR49","doi-asserted-by":"publisher","first-page":"D488","DOI":"10.1093\/nar\/gkac1077","volume":"51","author":"SK Burley","year":"2023","unstructured":"Burley SK, Bhikadiya C, Bi C, Bittrich S, Chao H, Chen L, et al. RCSB Protein Data Bank (RCSB. org): delivery of experimentally-determined PDB structures alongside one million computed structure models of proteins from artificial intelligence\/machine learning. Nucleic Acids Res. 2023;51:D488\u2013D508.","journal-title":"Nucleic Acids Res"},{"key":"1701_CR50","unstructured":"Maestro S Maestro. Schr\u00f6dinger, LLC, New York, NY. 2020;2020:682."},{"key":"1701_CR51","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1021\/ci100026x","volume":"50","author":"IJ Chen","year":"2010","unstructured":"Chen IJ, Foloppe N. Drug-like bioactive structures and conformational coverage with the LigPrep\/ConfGen suite: comparison to programs MOE and catalyst. J Chem Inf Model. 2010;50:822\u201339.","journal-title":"J Chem Inf Model"},{"key":"1701_CR52","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1021\/ct200908r","volume":"8","author":"SWI Siu","year":"2012","unstructured":"Siu SWI, Pluhackova K, B\u00f6ckmann RA. Optimization of the OPLS-AA force field for long hydrocarbons. J Chem Theory Comput. 2012;8:1459\u201370.","journal-title":"J Chem Theory Comput"},{"key":"1701_CR53","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren TA, Murphy RB, Friesner RA, Beard HS, Frye LL, Pollard WT, et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem. 2004;47:1750\u20139.","journal-title":"J Med Chem"},{"key":"1701_CR54","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3390\/molecules28031035","volume":"28","author":"Silva","year":"2023","unstructured":"Silva, Ferreira LB, Maryam EFB, Espejo-Rom\u00e1n JM, Costa GV, Cruz JV, et al. Galantamine based novel acetylcholinesterase enzyme inhibitors: a molecular modeling design approach. Molecules. 2023;28:1035.","journal-title":"Molecules"},{"key":"1701_CR55","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.14936","volume":"11","author":"N Yousaf","year":"2023","unstructured":"Yousaf N, Alharthy RD, Kamal I, Saleem M, Muddassar M. others. Identification of human phosphoglycerate mutase 1 (PGAM1) inhibitors using hybrid virtual screening approaches. PeerJ. 2023;11:e14936.","journal-title":"PeerJ"},{"key":"1701_CR56","doi-asserted-by":"crossref","unstructured":"Kausar N, Shier WT, Ahmed M, Maryam, Albekairi NA, Alshammari A, et al. Investigation of the insecticidal potential of curcumin derivatives that target the Helicoverpa armigera sterol carrier protein-2. Heliyon. 2024;10:e29695.","DOI":"10.1016\/j.heliyon.2024.e29695"},{"key":"1701_CR57","doi-asserted-by":"publisher","first-page":"3747","DOI":"10.3390\/ijms25073747","volume":"25","author":"A Parvez","year":"2024","unstructured":"Parvez A, Lee JS, Alam W, Tayara H, Chong KT. Integrated computational approaches for drug design targeting cruzipain. Int J Mol Sci. 2024;25:3747.","journal-title":"Int J Mol Sci"},{"key":"1701_CR58","doi-asserted-by":"crossref","unstructured":"Duan J, Dixon SL, Lowrie JF, Sherman W. Analysis and comparison of 2D fingerprints: Insights into database screening performance using eight fingerprint methods. J Molec Graph Model. 2010;29:157\u201370.","DOI":"10.1016\/j.jmgm.2010.05.008"},{"key":"1701_CR59","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1021\/acs.jctc.1c00136","volume":"17","author":"EB Miller","year":"2021","unstructured":"Miller EB, Murphy RB, Sindhikara D, Borrelli KW, Grisewood MJ, Ranalli F, et al. Reliable and accurate solution to the induced fit docking problem for protein-ligand binding. J Chem Theory Comput. 2021;17:2630\u20139.","journal-title":"J Chem Theory Comput"},{"key":"1701_CR60","doi-asserted-by":"crossref","unstructured":"Cao Y, Balduf T, Beachy MD, Bennett MC, Bochevarov AD, Chien A, et al. Quantum chemical package Jaguar: A survey of recent developments and unique features. J Chem Phys. 2024;161:052502.","DOI":"10.1063\/5.0213317"},{"key":"1701_CR61","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/jcc.20289","volume":"26","author":"JC Phillips","year":"2005","unstructured":"Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, et al. Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26:1781\u2013802.","journal-title":"J Comput Chem"},{"key":"1701_CR62","first-page":"257","volume":"56","author":"JrAD MacKerell","year":"2000","unstructured":"MacKerell JrAD, Banavali N, Foloppe N. Development and current status of the CHARMM force field for nucleic acids. Biopolym Orig Res Biomol. 2000;56:257\u201365.","journal-title":"Biopolym Orig Res Biomol"},{"key":"1701_CR63","doi-asserted-by":"crossref","unstructured":"Harrach MF, Drossel B. Structure and dynamics of TIP3P, TIP4P, and TIP5P water near smooth and atomistic walls of different hydroaffinity. J Chem Phys. 2014;140. Available from: https:\/\/pubs.aip.org\/jcp\/article\/140\/17\/174501\/317226\/Structure-and-dynamics-of-TIP3P-TIP4P-and-TIP5P","DOI":"10.1063\/1.4872239"},{"key":"1701_CR64","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG. A smooth particle mesh Ewald method. J Chem Phys. 1995;103:8577\u201393.","journal-title":"J Chem Phys"},{"key":"1701_CR65","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V","volume":"22","author":"V Kr\u00e4utler","year":"2001","unstructured":"Kr\u00e4utler V, Van Gunsteren WF, H\u00fcnenberger PH. A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. J Comput Chem. 2001;22:501\u20138.","journal-title":"J Comput Chem"},{"key":"1701_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.physa.2019.122210","volume":"534","author":"O Farago","year":"2019","unstructured":"Farago O. Langevin thermostat for robust configurational and kinetic sampling. Phys A Stat Mech Its Appl. 2019;534:122210.","journal-title":"Phys A Stat Mech Its Appl"},{"key":"1701_CR67","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K. VMD: visual molecular dynamics. J Mol Graph. 1996;14:33\u20138.","journal-title":"J Mol Graph"},{"key":"1701_CR68","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","volume":"16","author":"T Tuccinardi","year":"2021","unstructured":"Tuccinardi T. What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery?. Expert Opin Drug Discov. 2021;16:1233\u20137.","journal-title":"Expert Opin Drug Discov"},{"key":"1701_CR69","doi-asserted-by":"crossref","unstructured":"Case DA, Cheatham TE 3rd, Darden T, Gohlke H, Luo R, Merz KM Jr, et al. The Amber biomolecular simulation programs. J Comput Chem. 2005;26:1668\u201388.","DOI":"10.1002\/jcc.20290"},{"key":"1701_CR70","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"E Wang","year":"2019","unstructured":"Wang E, Sun H, Wang J, Wang Z, Liu H, Zhang JZH, et al. End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev. 2019;119:9478\u2013508.","journal-title":"Chem Rev"},{"key":"1701_CR71","doi-asserted-by":"publisher","first-page":"6487","DOI":"10.1021\/acs.jcim.3c01090","volume":"63","author":"M Yasir","year":"2023","unstructured":"Yasir M, Park J, Han ET, Park WS, Han JH, Kwon YS, et al. Machine learning-based drug repositioning of novel janus Kinase 2 Inhibitors utilizing molecular docking and molecular dynamic simulation. J Chem Inf Model. 2023;63:6487\u2013500.","journal-title":"J Chem Inf Model"},{"key":"1701_CR72","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1007\/s00204-024-03756-9","volume":"98","author":"H Zahid","year":"2024","unstructured":"Zahid H, Tayara H, Chong KT. Harnessing machine learning to predict cytochrome P450 inhibition through molecular properties. Arch Toxicol. 2024;98:2647\u201358.","journal-title":"Arch Toxicol"},{"key":"1701_CR73","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/qsar.200730051","volume":"27","author":"L Ioakimidis","year":"2008","unstructured":"Ioakimidis L, Thoukydidis L, Mirza A, Naeem S, Reynisson J. Benchmarking the reliability of QikProp. Correlation between experimental and predicted values. QSAR Comb Sci. 2008;27:445\u201356.","journal-title":"QSAR Comb Sci"},{"key":"1701_CR74","doi-asserted-by":"crossref","unstructured":"Mohan A, Rendine N, Mohammed MKS, Jeeva A, Ji HF, Talluri VR. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 Mpro. Mol Divers. 2022;26:1645\u201361.","DOI":"10.1007\/s11030-021-10298-0"},{"key":"1701_CR75","unstructured":"Shah R, Silwal S. Using dimensionality reduction to optimize t-sne. Preprint arXiv:1912.01098. 2019."},{"key":"1701_CR76","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/wics.101","volume":"2","author":"H Abdi","year":"2010","unstructured":"Abdi H, Williams LJ. Principal component analysis. Wiley Interdiscip Rev Comput Stat. 2010;2:433\u201359.","journal-title":"Wiley Interdiscip Rev Comput Stat"},{"key":"1701_CR77","unstructured":"Bowen D, Ungar L. Generalized SHAP: Generating multiple types of explanations in machine learning. Preprint at https:\/\/arXiv\/org\/2006.07155. 2020."},{"key":"1701_CR78","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","volume":"13","author":"K Sargsyan","year":"2017","unstructured":"Sargsyan K, Grauffel C, Lim C. How molecular size impacts RMSD applications in molecular dynamics simulations. J Chem Theory Comput. 2017;13:1518\u201324.","journal-title":"J Chem Theory Comput"},{"key":"1701_CR79","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/bioinformatics\/bts445","volume":"28","author":"E Fuglebakk","year":"2012","unstructured":"Fuglebakk E, Echave J, Reuter N. Measuring and comparing structural fluctuation patterns in large protein datasets. Bioinformatics. 2012;28:2431\u201340.","journal-title":"Bioinformatics"},{"key":"1701_CR80","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov MY, Bogatyreva NS, Galzitskaya OV. Radius of gyration as an indicator of protein structure compactness. Mol Biol. 2008;42:623\u20138.","journal-title":"Mol Biol"},{"key":"1701_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04443-6","volume":"21","author":"Z Wang","year":"2023","unstructured":"Wang Z, Sun L, Xu Y, Liang P, Xu K, Huang J. Discovery of novel JAK1 inhibitors through combining machine learning, structure-based pharmacophore modeling and bio-evaluation. J Transl Med. 2023;21:579.","journal-title":"J Transl Med"},{"key":"1701_CR82","doi-asserted-by":"publisher","first-page":"33548","DOI":"10.1021\/acsomega.2c04535","volume":"7","author":"K Sanachai","year":"2022","unstructured":"Sanachai K, Mahalapbutr P, Hengphasatporn K, Shigeta Y, Seetaha S, Tabtimmai L, et al. Pharmacophore-based virtual screening and experimental validation of pyrazolone-derived inhibitors toward janus kinases. ACS Omega. 2022;7:33548\u201359.","journal-title":"ACS Omega"},{"key":"1701_CR83","doi-asserted-by":"crossref","unstructured":"Zahid H, Chong KT, Tayara H. Integrating graph convolution and attention mechanism for kinase inhibition prediction. Molecules. 2025;30:2871. Available from: https:\/\/www.mdpi.com\/1420-3049\/30\/13\/2871","DOI":"10.3390\/molecules30132871"},{"key":"1701_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22992-6","volume":"12","author":"A Salimi","year":"2022","unstructured":"Salimi A, Lim JH, Jang JH, Lee JY. The use of machine learning modeling, virtual screening, molecular docking, and molecular dynamics simulations to identify potential VEGFR2 kinase inhibitors. Sci Rep. 2022;12:18825.","journal-title":"Sci Rep"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01701-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01701-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:05:05Z","timestamp":1777025105000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-025-01701-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":84,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1701"],"URL":"https:\/\/doi.org\/10.1038\/s41401-025-01701-9","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"15 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}